Re-introduction of miR-133b into GC cells can obviously inhibit GC cell proliferation, migration and invasion and the tumor suppressor roles of miR-133b in GC was partially through targeting oncogenic FSCN1. The gene discussed is FSCN1; the disease is gastric cancer.